Applications

1435 – Processing and Cryopreservation of Male and Female Gonadal Tissue and Gametes Prior to or after Gonadotoxic Treatment to Preserve Fertility for the Future

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome -

Application details

Reason for application

New MBS item.

Service or technology in this application

The Applicant is seeking a review of the following proposed medical services:

Processing and handling of ovarian tissue in preparation for cryostorage as part of fertility preservation treatment for female patients who have or will receive gonadotoxic treatment.

Processing and handling of semen in preparation for cryostorage as part of fertility preservation treatment for male patients who have or will receive gonadotoxic treatment.

Processing and handling of testicular tissue in preparation for cryostorage as part of fertility preservation treatment for male patients who have or will receive gonadotoxic treatment.

Type: Therapeutic

Medical condition this application addresses

The proposed patient population is defined by the requirement of gonadotoxic therapy. Two distinct patient populations may be defined:

  1. Patients diagnosed with malignancy
  2. Patients diagnosed with non-malignant conditions receiving gonadotoxic treatment

Application documents

Meetings to consider this application

  • PASC meeting: 11 - 12 August 2016
  • ESC meeting: 
    • 5 October 2017 - Part A - Male
    • 8 - 9 February 2018 - Part B - Female
  • MSAC meeting: 
    • 23 November 2017 - Part A - Male
    • 28 - 29 March 2018 - Part B - Female